Literature DB >> 3827339

Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill: another report.

M H Miller.   

Abstract

I report the case of a woman with systemic lupus erythematosus who had pulmonary hypertension unassociated with chronic interstitial lung disease or pulmonary emboli. She had started taking the contraceptive pill seven months previously.

Entities:  

Keywords:  Antibodies; Australia; Autoimmune Response; Biology; Blood Pressure; Cardiovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--complications; Demographic Factors; Dermatological Effects; Diseases; Ethinyl Estradiol; Family Planning; Hemic System; Hypertension; Immunity; Immunologic Factors; Immunological Effects; Levonorgestrel; Mortality; Oceania; Oral Contraceptives, Combined; Oral Contraceptives, Low-dose; Oral Contraceptives--complications; Physiology; Population; Population Dynamics; Pulmonary Effects; Respiratory Insufficiency; Systemic Lupus Erythematosus; Vascular Diseases

Mesh:

Substances:

Year:  1987        PMID: 3827339      PMCID: PMC1002084          DOI: 10.1136/ard.46.2.159

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  Oral contraceptives and progressive pulmonary vascular disease.

Authors:  C Oakley; J Somerville
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

2.  Pulmonary hypertension and systemic lupus erythematosus.

Authors:  R A Asherson; C M Oakley
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

3.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  R A Asherson; C G Mackworth-Young; M L Boey; R G Hull; A Saunders; A E Gharavi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

4.  Pulmonary hypertension in patients using oral contraceptives. A report of six cases.

Authors:  R E Kleiger; M Boxer; R E Ingham; D C Harrison
Journal:  Chest       Date:  1976-02       Impact factor: 9.410

5.  Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.

Authors:  M L Mahowald; E K Weir; D J Ridley; R P Messner
Journal:  J Rheumatol       Date:  1985-08       Impact factor: 4.666

6.  Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus.

Authors:  F P Quismorio; O Sharma; M Koss; T Boylen; A W Edmiston; P J Thornton; D Tatter
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

7.  Systemic lupus erythematosus in males.

Authors:  M H Miller; M B Urowitz; D D Gladman; D W Killinger
Journal:  Medicine (Baltimore)       Date:  1983-09       Impact factor: 1.889

8.  Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill.

Authors:  G R Todd; E J McAteer; C M Jack; M Haire; S D Roberts; K D Buchanan
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

  8 in total
  4 in total

1.  4,4'-Methylenedianiline Alters Serotonergic Transport in a Novel, Sex-Specific Model of Pulmonary Arterial Hypertension in Rats.

Authors:  Michelle Carroll-Turpin; Valeria Hebert; Tanya Chotibut; Heather Wensler; Dallas Krentzel; Kurt James Varner; Brendan R Burn; Yi-Fan Chen; Fleurette Abreo; Tammy Renee Dugas
Journal:  Toxicol Sci       Date:  2015-06-26       Impact factor: 4.849

2.  Primary pulmonary hypertension associated with systemic lupus erythematosus.

Authors:  A Turner; A Samanta; F E Nichol
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

3.  Interferon Genes Are Influenced by 17β-Estradiol in SLE.

Authors:  Ram P Singh; Bevra H Hahn; David S Bischoff
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

4.  Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus.

Authors:  Ji-Won Kim; Hyoun-Ah Kim; Chang-Hee Suh; Ju-Yang Jung
Journal:  Front Med (Lausanne)       Date:  2022-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.